The company raised full year 2026 revenue guidance to USD 8.530 billion to USD 8.534 billion. No specific cause for the decline was stated, but total contract value closed was USD 2.918 billion, up only 6% year over year, compared with growth of 49% …
Revenue was USD 17.7 million, up from USD 8.9 million a year earlier, and full year 2026 revenue guidance was raised to USD 52 million to USD 57 million. The net loss was USD 119.1 million. Cash fell to USD 1,343.1 million at September …
Second quarter 2026Revenuewas USD 33 thousand, with a net loss attributable to common stockholders of about USD 5.5 million. Cash was USD 3.8 million at June 30, 2026 against six-month operating expenses of USD 15.1 million, so cash covers roughly one quarter of spending …
The company will also issue 1,500 further Class C preferred shares as an inducement. Class A shares outstanding were 361,361 as of June 30, 2026, adjusted for one-for-nine consolidations on July 2, 2026 and September 28, 2026, although the share count at the conversion …
Haoxi Health Technology (NASDAQ:HAO) was down 10.89% to USD 1.75 in pre-market trading on November 3, 2026. No company announcement dated October 30 to November 3, 2026 was identified, so the move reads as price action rather than news. Under USD 5, it is …
No specific cause for the decline was stated. Total contract value closed was USD 2.918 billion, up only 6% year over year, compared with 49% growth in the second quarter. Cash and US Treasuries totaled USD 10.4 billion with noDebtlisted, so the debate centers …
Nasdaq staff determined on October 8, 2026 to delist the shares for missing the USD 2.5 million stockholders'Equityrequirement, and the company said it would request a hearing, which pauses the action. The CortigentMergerwith a Vivani MedicalSubsidiaryremained pending final regulatory approval as of October 30, …
Rising Dragon Acquisition (NASDAQ:RDAC) was up 101.37% to USD 10.27 in pre-market trading on November 3, 2026. A press release dated November 3, 2026 announced a mutual termination of the merger agreement with HZJL Cayman Limited, effective October 30, 2026, with no termination fee …
Mercer International (NASDAQ:MERC) was up 90.87% to USD 0.2405 in pre-market trading on November 3, 2026. The implied prior close is about USD 0.126 (calculated), so thisPenny Stockremains deeply depressed. A November 2, 2026 announcement outlined aRecapitalizationexchanging about USD 1.1 billion of senior notes …
Third quarter results are scheduled for November 3, 2026, with a call at 8:00 a.m. ET. The company expects to complete its rolling FDA submission for COMP360 in the fourth quarter of 2026, and COMP360 has not been approved. It has no product revenue, …